ProteaseTag® Active Neutrophil Elastase Immunoassay used to predict future risk of exacerbation in bronchiectasis Read More
ProAxsis successfully licenses additional intellectual property from The Queen’s University of Belfast Read More
ProAxsis to showcase ProteaseTag® abstracts at 2017 North American Cystic Fibrosis Conference Read More
ProAxsis to test ProteaseTag® Technology in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease at National Jewish Health Read More
ProAxsis Presenting New Data on NEATstik and New High Sensitivity Neutrophil Elastase Immunoassay at ATS 2018 Read More
ProAxsis to present data on novel immunoassay at 2018 British Thoracic Society Winter Meeting Read More
New data demonstrates high potential of NEATstik® as a rapid point-of-care monitoring tool for lung diseases Read More
ProAxsis Limited supported by Innovate UK to accelerate work on inflammatory biomarkers associated with COVID-19 Read More
ProAxsis Limited enters licensing agreement with top Swiss University as it continues to develop novel new products in the fight against fractures and other metabolic bone diseases Read More
Aptamer Group and ProAxsis Limited enter partnership to improve global logistics and stability of diagnostic tests Read More
ProAxsis expands inflammatory biomarker research via new partnership with Queen’s University Belfast Read More
ProAxsis enhances availability of product portfolio in Asia via new partnership with Kyberlife Read More
Protease Tag® Active Neutrophil Elastase Immunoassay used to predict future risk of exacerbation in bronchiectasis Read More
Measuring bone health with a new innovation for patients at high risk of osteoporotic fractures Read More
ProAxsis and Queen’s University of Belfast secure a second licensing agreement for exclusive intellectual property rights ProteaseTag® technology Read More
ProAxsis signs partnership agreement with US based Biotechnology company to develop two key respiratory proteases, utilizing ProteaseTag® technology, a platform technology that allows any protease to be targeted Read More
AAAAI (American Academy of Allergy, Asthma and Immunology) Annual Meeting San Antonio, TX 24-27 February 2023 Read More
Association of Medical Diagnostics Manufacturers IVD Regulatory Meeting Bethesda, MD 19-20 April,2023 Read More